AIM
AVNS

Achmea Investment Management’s Avanos Medical AVNS Stock Holding History

Achmea Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,691
Closed -$50K – 485
2020
Q2 		$50K Hold
1,691
– – ﹤0.01% 288
2020
Q1 		$46K Buy
+1,691
New +$50.5K ﹤0.01% 243

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Achmea Investment Management's AVNS Position: Q3 2020 in Review

Achmea Investment Management sold out of Avanos Medical (AVNS) in Q3 2020, closing a stake of 1,691 shares — an estimated $50K sold.

Achmea Investment Management first reported a position in AVNS in Q1 2020 and held it in 2 quarters. The position peaked at $50K in Q2 2020. 272 funds tracked by Wall St. Rank hold AVNS as of Q3 2020.

  • Achmea Investment Management reported no remaining Avanos Medical position as of Q3 2020 after selling out during the quarter.
  • Achmea Investment Management sold 1,691 Avanos Medical shares in Q3 2020, an estimated $50K.
  • Achmea Investment Management first reported a position in Avanos Medical in Q1 2020 and held it in 2 quarters.
  • Achmea Investment Management's Avanos Medical position peaked at $50K in Q2 2020.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2020.

Based on Achmea Investment Management's 13F filing for Q3 2020, filed 2 Nov 2020.